- Report
- March 2024
- 194 Pages
Global
From €3283EUR$3,374USD£2,812GBP
€3648EUR$3,749USD£3,125GBP
- Report
- February 2021
- 420 Pages
United States
From €2335EUR$2,400USD£2,000GBP
- Report
- September 2019
- 40 Pages
Saudi Arabia
From €2525EUR$2,595USD£2,163GBP
- Report
- September 2019
- 40 Pages
United States
From €2525EUR$2,595USD£2,163GBP
- Report
- September 2019
- 40 Pages
Russia
From €2525EUR$2,595USD£2,163GBP
- Report
- September 2019
- 40 Pages
Ireland
From €2525EUR$2,595USD£2,163GBP
- Report
- September 2019
- 40 Pages
Germany
From €2525EUR$2,595USD£2,163GBP
- Report
- September 2019
- 40 Pages
France
From €2525EUR$2,595USD£2,163GBP
- Report
- April 2024
- 50 Pages
Global
From €2578EUR$2,650USD£2,209GBP
- Report
- April 2024
- 50 Pages
Global
From €2578EUR$2,650USD£2,209GBP
Trimipramine is a tricyclic antidepressant (TCA) used to treat mental disorders such as depression, anxiety, and obsessive-compulsive disorder (OCD). It is a member of the dibenzazepine class of drugs, which are known for their sedative and anticholinergic effects. Trimipramine is also used to treat chronic pain, and is sometimes used off-label to treat attention deficit hyperactivity disorder (ADHD).
Trimipramine is available in both generic and brand-name formulations. It is typically taken orally, and is available in tablet, capsule, and liquid forms. The drug is usually taken once or twice daily, depending on the condition being treated.
Trimipramine is generally well-tolerated, but can cause side effects such as dry mouth, constipation, blurred vision, and dizziness. It can also interact with other medications, so it is important to discuss all medications with a doctor before taking trimipramine.
Some companies that produce trimipramine include Pfizer, Mylan, and Sandoz. Show Less Read more